HPV vax cuts risk of disease recurrence

The HPV vaccine confers lasting benefits for women who develop pre-cancerous cervical or vulval lesions in the years after vaccination, research suggests.

An international study has shown for the first time that women who develop HPV-related cervical disease warranting surgery are significantly less likely to experience disease recurrence if they had been previously vaccinated in early adulthood.

Among women who underwent cervical surgery for HPV-related disease,